111 Total Long Term Liabilities 2018-2024 | YI

111 total long term liabilities from 2018 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
111 Annual Total Long Term Liabilities
(Millions of US $)
2024 $151
2023 $132
2022 $168
2021 $183
2020 $152
2019 $9
2018 $1
2017 $228
111 Quarterly Total Long Term Liabilities
(Millions of US $)
2024-12-31 $151
2024-09-30 $145
2024-06-30 $128
2024-03-31 $131
2023-12-31 $132
2023-09-30 $123
2023-06-30 $162
2023-03-31 $168
2022-12-31 $168
2022-09-30 $163
2022-06-30 $173
2022-03-31 $184
2021-12-31 $183
2021-09-30 $178
2021-06-30 $164
2021-03-31 $159
2020-12-31 $152
2020-09-30 $70
2020-06-30 $8
2020-03-31 $9
2019-12-31 $9
2019-09-30 $9
2019-06-30 $7
2019-03-31 $7
2018-09-30
2017-12-31 $228
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.072B $1.973B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.097B 58.90
Hims & Hers Health (HIMS) United States $12.727B 132.23
Tempus AI (TEM) United States $11.588B 0.00
IRhythm Technologies (IRTC) United States $4.708B 0.00
Inspire Medical Systems (INSP) United States $4.030B 62.97
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.833B 193.67
Enovis (ENOV) United States $1.879B 10.48
Schrodinger (SDGR) United States $1.869B 0.00
Phreesia (PHR) United States $1.636B 0.00
Clover Health Investments (CLOV) United States $1.517B 0.00
Omnicell (OMCL) United States $1.484B 26.18
Azenta (AZTA) United States $1.340B 62.30
10x Genomics (TXG) United States $1.242B 0.00
Fulgent Genetics (FLGT) United States $0.664B 0.00
Claritev (CTEV) United States $0.633B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.549B 164.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
Outset Medical (OM) United States $0.376B 0.00
TruBridge (TBRG) United States $0.363B 805.67
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.139B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.125B 0.00
American Well (AMWL) United States $0.111B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.092B 3.52
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00